Erythropoietin.
作者信息
Beresford C H
机构信息
University of Otago Medical School, Dunedin.
出版信息
N Z Med J. 1989 Apr 26;102(866):185-6.
PMID:2652007
Abstract
摘要
相似文献
1
Erythropoietin.促红细胞生成素
N Z Med J. 1989 Apr 26;102(866):185-6.
2
Erythropoietin for anemia.
Med Lett Drugs Ther. 1989 Sep 22;31(801):85-6.
3
Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.重组人促红细胞生成素治疗终末期肾病所致贫血的美国多中心试验。
Contrib Nephrol. 1989;76:166-78; discussion 212-8.
4
Effect of recombinant human erythropoietin on the anemia of chronic renal failure.重组人促红细胞生成素对慢性肾衰竭贫血的影响。
Int J Cell Cloning. 1988 May;6(3):179-91. doi: 10.1002/stem.5530060304.
5
[Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
Med Clin (Barc). 1990 Nov 17;95(17):656-9.
6
Erythropoietin and chronic renal failure.
Nouv Rev Fr Hematol (1978). 1989;31(2):97-8.
7
[Erythropoietin, blood viscosity and hypertension in chronic kidney failure].[慢性肾衰竭中的促红细胞生成素、血液黏度与高血压]
Dtsch Med Wochenschr. 1989 Jun 30;114(26):1046-9. doi: 10.1055/s-0029-1235699.
8
Erythropoietin therapy in patients with chronic renal failure.慢性肾衰竭患者的促红细胞生成素治疗
West J Med. 1992 Aug;157(2):154-7.
9
The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.重组人促红细胞生成素（EPO）用于纠正终末期肾病贫血的进展报告。
Behring Inst Mitt. 1988 Aug(83):188-92.
10
[The use of erythropoietin].[促红细胞生成素的应用]
Ned Tijdschr Geneeskd. 1991 Feb 2;135(5):163-6.
Zotero 插件